Theratechnologies Files Application to List on NASDAQ

- August 12th, 2019

Theratechnologies (TSX:TH) has announced it has applied to list its common shares on the NASDAQ. As quoted in the press release: “We believe that being listed on NASDAQ will help to foster interest from more potential investors and financial analysts, and that it should result in increased liquidity for investors. Theratechnologies will enter NASDAQ with … Continued

Theratechnologies (TSX:TH) has announced it has applied to list its common shares on the NASDAQ.

As quoted in the press release:

“We believe that being listed on NASDAQ will help to foster interest from more potential investors and financial analysts, and that it should result in increased liquidity for investors. Theratechnologies will enter NASDAQ with a strong commercial portfolio and a research pipeline that will undoubtedly attract more attention and be better recognized,” said Philippe Dubuc, Senior Vice-President and Chief Financial Officer, Theratechnologies Inc.

In connection with its application to list on NASDAQ, Theratechnologies will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company’s common shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements. Based on its typical review process, it is expected that the Company’s common shares will be listed on NASDAQ within the next 60 days.

The Company will maintain its common share listing on the Toronto Stock Exchange under the symbol “TH”.

Click here to read the full press release.

 

We found the top performing pharma stocks to watch this year

Find out more in our report
 

Leave a Reply

Your email address will not be published. Required fields are marked *